CYTEK BIOSCIENCES, INC. Payments to Acquire Real Estate Held-for-investment
CYTEK BIOSCIENCES, INC. (CTKB) reported Payments to Acquire Real Estate Held-for-investment of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireRealEstateHeldForInvestment · last filed 2025-02-28
- CYTEK BIOSCIENCES, INC. payments to acquire real estate held-for-investment for the quarter ending 2023-12-31 was $0.00.
- CYTEK BIOSCIENCES, INC. payments to acquire real estate held-for-investment for the quarter ending 2023-09-30 was $0.00.
- CYTEK BIOSCIENCES, INC. payments to acquire real estate held-for-investment for the quarter ending 2022-12-31 was $0.00.
- CYTEK BIOSCIENCES, INC. payments to acquire real estate held-for-investment for the quarter ending 2022-09-30 was $0.00.
- CYTEK BIOSCIENCES, INC. payments to acquire real estate held-for-investment for fiscal 2024 was $0.00.
- CYTEK BIOSCIENCES, INC. payments to acquire real estate held-for-investment for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. payments to acquire real estate held-for-investment for fiscal 2022 was $1.59M.
- CYTEK BIOSCIENCES, INC. payments to acquire real estate held-for-investment for fiscal 2021 was $0.00.
| Period end | Payments to Acquire Real Estate Held-for-investment 3 month | Payments to Acquire Real Estate Held-for-investment 6 month | Payments to Acquire Real Estate Held-for-investment 9 month | Payments to Acquire Real Estate Held-for-investment 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $1.59M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.59M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $1.59M 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $0.00 derived: sum of 2 quarters · filed 2024-03-13 | $0.00 10-K · filed 2024-03-13 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |